Sort
23,748 grants matching “melanoma”
Clinical Protocol and Data Management/Clinical Trials Office (Core 016)
$532,275Adam M Brufsky · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · CA
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$532,216Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Immunologic Monitoring and Cellular Products Laboratory
$532,212Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P30 · FY2019 · CA
Immunologic Monitoring and Cellular Products Laboratory
$532,212Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · CA
A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors
$532,072Barry Jones · Arisaph Pharmaceuticals, Inc. · R42 · FY2015 · CA
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
$531,996Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer
$531,968Sara Lindstroem · University Of Washington · R01 · FY2021 · CA
Computational Methods for Identifying Non-coding Cancer Drivers
$531,893Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA
Targeting Tumors with NF1 Loss
$531,751Yolanda Sanchez · Dartmouth College · R01 · FY2019 · NS
Targeting Lymph Node Dependent Immune Tolerance in Cancer
$531,707Edgar G. Engleman · Stanford University · R01 · FY2021 · CA
The role of IWS1 in development and tumorigenesis
$531,687Philip N Tsichlis · Tufts Medical Center · R01 · FY2016 · CA
The role of IWS1 in development and tumorigenesis
$531,687Philip N Tsichlis · Tufts Medical Center · R01 · FY2017 · CA
HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers
$531,650Douglas F Nixon · George Washington University · R01 · FY2016 · CA
MAINLINE HEALTH CCOP
$531,351Lankenau Institute For Medical Research · U10 · FY2002 · CA
Apigenin restores TSP-1 expression in UVB-irradiated keratinocytes
$531,313Jill C. Pelling · Northwestern University At Chicago · R01 · FY2013 · CA
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
$531,105Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
The Tumor Microenvironment Niche of Type I conventional Dendritic Cells
$531,064Matthew F Krummel · University Of California, San Francisco · R01 · FY2023 · CA
The Tumor Microenvironment Niche of Type I conventional Dendritic Cells
$531,064Matthew F Krummel · University Of California, San Francisco · R01 · FY2025 · CA
Peri-operative confocal imaging-guided laser ablation of basal cell carcinomas
$530,979Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2015 · EB
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$530,976Kathryn Miller-Jensen · Yale University · U01 · FY2024 · CA
MULTIMODAL PRECISION LIQUID BIOPSY TO PREDICT RISK OF MELANOMA RECURRENCE
$530,887Macquarie University · · FY2022 · Defense Health Agency
Project 1: Identifying new therapeutic avenues to selectively target tumors with uncontrolled mTORC1 activation
$530,842David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2023 · CA
Integrated Discovery Pipeline for Tumor Neoantigens
$530,736Beatriz M. Carreno · University Of Pennsylvania · R01 · FY2019 · CA
Data Analysis Unit
$530,623Aviv Regev · Dana-Farber Cancer Inst · U2C · FY2018 · CA
Targeting the gut microbiome to inhibit melanoma lymph node metastases
$530,612Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA